The American psychiatric association practice guideline for the pharmacological treatment of patients with alcohol use disorder
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APA practice guidelines recommend pharmacotherapy in conjunction with psychosocial interventions for patients with moderate or severe AUD.
“The practice guidelines of the American Psychiatric Association (APA) recommends pharmacotherapy in conjunction with psychosocial interventions for patients with moderate or severe AUD [9].”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [9]
VA/DoD practice guidelines recommend topiramate in AUD, while APA guidelines suggest topiramate and gabapentin in addition to the three FDA-approved medications.
“Additionally, The VA/DoD practice guidelines recommend the use of topiramate in AUD, while the APA guidelines suggest topiramate and gabapentin in addition to the three FDA-approved medications [9,47].”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [9]
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · see citing works
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,102 · see citing works
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556 · see citing works
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930 · see citing works
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,332 · see citing works
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220 · see citing works
Economic costs of excessive alcohol consumption in the U.S., 2006
Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · cited 1× · see citing works
“According to a 2006 Centers for Disease Control and Prevention-sponsored study (Bouchery et al., 2011), AUD and its sequelae cost the U.S. $223.5 billion annually and account for significant excessmortality (Kendler etal., 2016).”
MethodInfluentialAlcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246 · see citing works
(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 205 · see citing works
Estimating the effect of help‐seeking on achieving recovery from alcohol dependence
Dawson, D. A., Grant, B. F., Stinson, F. S., & Chou, P. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01433.x · Cited by 197 · see citing works
Alcohol Use Disorder and Mortality Across the Lifespan
Kendler, K. S., Ohlsson, H., Sundquist, J., & Sundquist, K. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0360 · Cited by 103 · see citing works
Martin, G. W., & Rehm, J. T. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700604 · Cited by 92 · see citing works
The Endocrine Society Guidelines: When the Confidence Cart Goes Before the Evidence Horse
Brito, J. P., Domecq, J. P., Murad, M. H., Guyatt, G. H., & Montori, V. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1814 · Cited by 74 · see citing works
Timko, C., Rubinsky, A. D., Moos, B. S., & Moos, R. H. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00206.x · Cited by 55 · see citing works
Impact of quality of evidence on the strength of recommendations: an empirical study
Djulbegović, B., Trikalinos, T. A., Roback, J. D., Chen, R., & Guyatt, G. H. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-120 · Cited by 48 · see citing works
A guide to GRADE guidelines for the readers of JTH
Guyatt, G. H., Eikelboom, J. W., Akl, E. A., Crowther, M. A., Gutterman, D. D., Kahn, S. R., Schünemann, H. J., & Hirsh, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12320 · Cited by 47 · see citing works
A comparative quality assessment of evidence‐based clinical guidelines in endocrinology
Hazlehurst, J., Armstrong, M. J., Sherlock, M., Rowe, I. A. C., O’Reilly, M., Franklyn, J. A., Stewart, P. M., & Tomlinson, J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04441.x · Cited by 44 · see citing works
Slade, T. N., Chiu, W., Glantz, M. D., Kessler, R. C., Lago, L., Sampson, N. A., Al‐Hamzawi, A., Florescu, S., Moskalewicz, J., Murphy, S., et al. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13134 · Cited by 37 · see citing works
008 Principles for the Development of Specialty Society Clinical Guidelines
Fulda, G. J., Wolfkiel, C. J., Begolka, W. S., Campos‐Outcalt, D., Groman, R. F., Rubin, K., Davidson, C., May, C., Starkey, M., & Qaseem, A. (2013) · BMJ Quality & Safety · doi:10.1136/bmjqs-2013-002293.39 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580 · see citing works
Chung, M. K., Eckhardt, L. L., Chen, L. Y., Ahmed, H. M., Gopinathannair, R., Joglar, J. A., Noseworthy, P. A., Pack, Q. R., Sanders, P., & Trulock, K. M. (2020) · Circulation · doi:10.1161/cir.0000000000000748 · Cited by 549 · see citing works
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Rogal, S. S., Youk, A. O., Zhang, H., Gellad, W. F., Fine, M. J., Good, C. B., Chartier, M., DiMartini, A. F., Morgan, T. R. M., Bataller, R. A., et al. (2019) · Hepatology · doi:10.1002/hep.31042 · Cited by 225 · see citing works
Hazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 235 · see citing works
Chuong, V., Farokhnia, M., Khom, S., Pince, C. L., Elvig, S. K., Vlkolinsky, R., Marchette, R. C. N., Koob, G. F., Roberto, M., Vendruscolo, L. F., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.170671 · Cited by 214 · see citing works
Arab, J. P., Díaz, L. A., Rehm, J. T., Im, G. Y., Arrese, M. A., Kamath, P. S., Lucey, M. R., Mellinger, J. L., Thiele, M. S., Thursz, M. R., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.11.028 · Cited by 186 · see citing works
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169 · see citing works
Mental health management of elite athletes during COVID-19: a narrative review and recommendations
Reardon, C. L., Bindra, A., Blauwet, C. A., Budgett, R., Campriani, N., Currie, A., Gouttebarge, V., Mcduff, D. R., Mountjoy, M. L., Purcell, R., et al. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102884 · Cited by 145 · see citing works
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
Agabio, R., Sinclair, J., Addolorato, G., Aubin, H., Beraha, E. M., Caputo, F., Chick, J., Selle, P. D. L., Franchitto, N., Garbutt, J. C., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30303-1 · Cited by 137 · see citing works
Use of Medications for Alcohol Use Disorder in the US
Han, B., Jones, C. M., Einstein, E. B., Powell, P. A., & Compton, W. M. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1271 · Cited by 135 · see citing works
Arab, J. P., Izzy, M. J., Leggio, L., Bataller, R. A., & Shah, V. H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00527-0 · Cited by 126 · see citing works
Disulfiram: Mechanisms, Applications, and Challenges
Lanz, J., Biniaz-Harris, N., Kuvaldina, M., Jain, S., Lewis, K., & Fallon, B. A. (2023) · Antibiotics · doi:10.3390/antibiotics12030524 · Cited by 125 · see citing works
A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder
Kranzler, H. R., Feinn, R., Morris, P., & Hartwell, E. E. (2019) · Addiction · doi:10.1111/add.14655 · Cited by 121 · see citing works
Henssler, J. F., Müller, M., Carreira, H., Bschor, T., Heinz, A., & Baethge, C. (2020) · Addiction · doi:10.1111/add.15329 · Cited by 101 · see citing works
Alsuhaibani, R., Smith, D. C., Lowrie, R., Aljhani, S., & Paudyal, V. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03188-0 · Cited by 98 · see citing works
Nielsen, D. G., Andersen, K., Nielsen, A. S., Juhl, C. B., & Mellentin, A. I. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.006 · Cited by 84 · see citing works
Stigmatization of people with addiction by health professionals: Current knowledge. A scoping review
Cazalis, A., Lambert, L., & Auriacombe, M. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100196 · Cited by 92 · see citing works
Harris, M. T. H., Schiff, D. M., Saia, K., Muftu, S., Standish, K. R., & Wachman, E. M. (2023) · Breastfeeding Medicine · doi:10.1089/bfm.2023.29256.abm · Cited by 108 · see citing works
Rabiee, A., Mahmud, N., Falker, C. G., García–Tsao, G., Taddei, T. H., & Kaplan, D. E. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000093 · Cited by 78 · see citing works
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
de Beaurepaire, R., Sinclair, J. M. A., Heydtmann, M., Addolorato, G., Aubin, H.-J., Beraha, E. M., Caputo, F., Chick, J. D., de La Selle, P., Franchitto, N., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00708 · Cited by 95 · see citing works
Technology‐Delivered Cognitive‐Behavioral Interventions for Alcohol Use: A Meta‐Analysis
Kiluk, B. D., Ray, L. A., Walthers, J., Bernstein, M. H., Tonigan, J. S., & Magill, M. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14189 · Cited by 76 · see citing works
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
Fairbanks, J., Umbreit, A., Kolla, B. P., Karpyak, V. M., Schneekloth, T. D., Loukianova, L. L., & Sinha, S. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.01.030 · Cited by 74 · see citing works
Bahji, A., Bach, P., Danilewitz, M., Crockford, D. N., Devoe, D. J. A., el‐Guebaly, N., & Saitz, R. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000992 · Cited by 72 · see citing works
Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder
Arab, J. P., Addolorato, G., Mathurin, P., & Thursz, M. R. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.017 · Cited by 71 · see citing works
Integrating Treatment for Co-Occurring Mental Health Conditions
Yule, A. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.07 · Cited by 63 · see citing works
Evidence-Based Treatment of Young Adults With Substance Use Disorders
Hadland, S. E., Yule, A. M., Levy, S., Hallett, E., Silverstein, M., & Bagley, S. M. (2021) · PEDIATRICS · doi:10.1542/peds.2020-023523d · Cited by 69 · see citing works
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
Staufer, K., & Stauber, R. E. (2023) · Biomedicines · doi:10.3390/biomedicines11082108 · Cited by 63 · see citing works
Anticraving therapy for alcohol use disorder: A clinical review
Shen, W. W. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12028 · Cited by 61 · see citing works
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Caputo, F., Domenicali, M., & Bernardi, M. (2018) · Hepatology · doi:10.1002/hep.30358 · Cited by 57 · see citing works
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 61 · see citing works
Caputo, F., Agabio, R., Vignoli, T., Patussi, V., Fanucchi, T., Cimarosti, P., Meneguzzi, C., Greco, G., Rossin, R., Parisi, M., et al. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1933-8 · Cited by 54 · see citing works
WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women
Thibaut, F., Chagraoui, A., Buckley, L., Gressier, F., Labad, J., Lamy, S., Potenza, M. N., Kornstein, S. G., Rondón, M. B., Riecher‐Rössler, A., et al. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1510185 · Cited by 56 · see citing works
Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge
Bernstein, E. Y., Baggett, T. P., Trivedi, S., Herzig, S. J., & Anderson, T. S. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3387 · Cited by 53 · see citing works
Baclofen for alcohol use disorder
Agabio, R., Saulle, R., Rösner, S., & Minozzi, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012557.pub3 · Cited by 52 · see citing works
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
Shirley, D.-A. T., Sharma, I., Warren, C. A., & Moonah, S. N. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.633194 · Cited by 48 · see citing works
Alcohol use disorder in community management of chronic liver diseases
Leggio, L., & Mellinger, J. L. (2022) · Hepatology · doi:10.1002/hep.32531 · Cited by 50 · see citing works
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Díaz, L. A., König, D., Weber, S., Ayares, G., Fuentealba, J. M., Vázquez, V., Bataller, R. A., Kamath, P. S., Winder, G. S., Leggio, L., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00380-7 · Cited by 50 · see citing works
The future of translational research on alcohol use disorder
Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H. C., Ewing, S. W. F., Jentsch, D., King, A. C., Mason, B. J., O’Malley, S. S., et al. (2020) · Addiction Biology · doi:10.1111/adb.12903 · Cited by 47 · see citing works
Practical outpatient pharmacotherapy for alcohol use disorder
Kim, Y., Hack, L. M., Ahn, E. S., & Kim, J. (2018) · Drugs in Context · doi:10.7573/dic.212308 · Cited by 46 · see citing works
Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models
Müller, T. E., Fontana, B. D., Bertoncello, K. T., Franscescon, F., Mezzomo, N. J., Canzian, J., Stefanello, F. V., Parker, M. O., Gerlai, R. T., & Rosemberg, D. B. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109873 · Cited by 46 · see citing works
Díaz, L. A., Winder, G. S., Leggio, L., Bajaj, J. S., Bataller, R. A., & Arab, J. P. (2023) · Hepatology · doi:10.1097/hep.0000000000000645 · Cited by 46 · see citing works
Donroe, J. H., & Edelman, E. J. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202210180 · Cited by 44 · see citing works
Medications for treating alcohol use disorder: A narrative review
Kranzler, H. R., & Hartwell, E. E. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15118 · Cited by 45 · see citing works
Jansen, J. M., van den Heuvel, O. A., van der Werf, Y. D., de Wit, S. J., Veltman, D. J., van den Brink, W., & Goudriaan, A. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00272 · Cited by 43 · see citing works
Advances in the understanding and management of alcohol-related liver disease
Thursz, M. R., & Lingford-Hughes, A. R. (2023) · BMJ · doi:10.1136/bmj-2023-077090 · Cited by 41 · see citing works
Borgundvaag, B., Bellolio, F., Miles, I., Schwarz, E. S., Sharif, S., Su, M. K., Baumgartner, K. T., Liss, D. B., Sheikh, H., Vogel, J. A., et al. (2024) · Academic Emergency Medicine · doi:10.1111/acem.14911 · Cited by 42 · see citing works
Madruga, C. S., Paim, T. L., Alves, H. N. P., Miguel, A. C., Massaro, L. T. S., Caetano, R., & Laranjeira, R. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0088 · Cited by 40 · see citing works
Gratacós‐Ginès, J., Bruguera, P., Pérez-Guasch, M., López-Lazcano, A., Borràs, R., Hernández-Évole, H., Pons-Cabrera, M. T., Lligoña, A., Bataller, R. A., Ginès, P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000570 · Cited by 39 · see citing works
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments
Prince, D. S., Nash, E., & Liu, K. (2023) · Drugs · doi:10.1007/s40265-023-01939-9 · Cited by 39 · see citing works
Cohen, S. M., Alexander, R. S., & Holt, S. R. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.003 · Cited by 39 · see citing works
Metabolic dysfunction and alcohol-associated liver disease (MetALD)
Gao, B., Arab, J. P., Liangpunsakul, S., Ding, W., Szabó, G., Mehal, W. Z., Wang, H., He, Y., Stärkel, P., Llorente, C., et al. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100319 · Cited by 42 · see citing works
Richardson, R. S., Sulima, A., Rice, K. C., Kucharczk, J. A., Janda, K. D., Nisbett, K. E., Koob, G. F., Vendruscolo, L. F., & Leggio, L. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109643 · Cited by 34 · see citing works
The use of person-centered language in scientific research articles focusing on alcohol use disorder
Hartwell, M. L., Naberhaus, B., Arnhart, C., Ottwell, R., Dunn, K. E., Rogers, T., Vassar, M. B., & Beaman, J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108209 · Cited by 33 · see citing works
Blanco-Gandía, M. C., & Rodríguez‐Arias, M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.007 · Cited by 33 · see citing works
Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients
Rittenberg, A., Hines, A. L., Alvanzo, A. A. H., & Chander, G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108174 · Cited by 32 · see citing works
Bernstein, E. Y., Baggett, T. P., Trivedi, S., Herzig, S. J., & Anderson, T. S. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0641 · Cited by 32 · see citing works
Smith, A. T., Hansen, J., & Colvard, M. D. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108440 · Cited by 30 · see citing works
Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder
Ehrie, J., Hartwell, E. E., Morris, P. E., Mark, T. L., & Kranzler, H. R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00047 · Cited by 29 · see citing works
Finn, S. W., Lundin, A., Sjöqvist, H., & Danielsson, A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108964 · Cited by 28 · see citing works
Daniel, J., Dumortier, J., Bello, A. D., Gamon, L., Molinari, N., Faure, S., Meszaros, M., Bedoya, J. U., Meunier, L., Monet, C., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100832 · Cited by 28 · see citing works
Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin
Singal, A. K., Leggio, L., & DiMartini, A. F. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000296 · Cited by 28 · see citing works
Oldfield, B. J., McGinnis, K. A., Edelman, E. J., Williams, E. C., Gordon, A. J., Akgün, K. M., Crystal, S., Fiellin, L. E., Gaither, J. R., Goulet, J. L., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.11.002 · Cited by 26 · see citing works
Anderson, E. S., Chamberlin, M., Zuluaga, M., Ullal, M., Hawk, K. F., McCormack, R. P., D’Onofrio, G., & Herring, A. A. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.05.013 · Cited by 26 · see citing works
Review article: current and emerging therapies for acute alcohol‐associated hepatitis
Rattan, P., & Shah, V. H. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16969 · Cited by 26 · see citing works
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Ali, D. N., Ali, H. M., Lopez, M. R., Kang, S., & Choi, D. (2024) · Cells · doi:10.3390/cells13040318 · Cited by 26 · see citing works
Alcohol Use Disorder in Older Adults
Fenollal-Maldonado, G., Brown, D. S., Hoffman, H. L., Kahlon, C. K., & Grossberg, G. T. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.006 · Cited by 26 · see citing works
Lee, S. H., Choe, J. W., Cheon, Y. K., Choi, M., Jung, M. K., Jang, D. K., Jo, J. H., Lee, J. M., Kim, E. J., Han, S. Y., et al. (2022) · Gut and Liver · doi:10.5009/gnl220108 · Cited by 25 · see citing works
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
Agabio, R., & Leggio, L. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00464 · Cited by 25 · see citing works
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25 · see citing works
Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity
Gianfratti, B., Tabach, R., Sakalem, M. E., Stessuk, T., Maia, L. O., & Carlini, E. A. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114865 · Cited by 25 · see citing works
Joudrey, P. J., Oldfield, B. J., Yonkers, K. A., O’Connor, P. G., Berland, G. K., & Edelman, E. J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108090 · Cited by 23 · see citing works
Treatment of alcohol use disorder in patients with liver disease
Nielsen, A. S., Askgaard, G., & Thiele, M. S. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.012 · Cited by 23 · see citing works
Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.016 · Cited by 23 · see citing works
Pharmacotherapeutic options for co-morbid depression and alcohol dependence
Hillemacher, T., & Frieling, H. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1561870 · Cited by 23 · see citing works
Agabio, R., López‐Pelayo, H., Bruguera, P., Huang, S., Sardo, S., Peciña, M., Krupitsky, E. M., Fitzmaurice, G. M., & Lin, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107454 · Cited by 24 · see citing works
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Kelty, E. A., Terplan, M., Greenland, M., & Preen, D. B. (2021) · Drugs · doi:10.1007/s40265-021-01509-x · Cited by 25 · see citing works
Nicola, M. D., Pepe, M., Panaccione, I., Moccia, L., Dattoli, L., Molinaro, M., Sani, G., Janiri, L., & McIntyre, R. S. (2020) · CNS Spectrums · doi:10.1017/s109285292000173x · Cited by 22 · see citing works
Chichetto, N. E., Kundu, S., Freiberg, M. S., Koethe, J. R., Butt, A. A., Crystal, S., So-Armah, K. A., Cook, R. L., Braithwaite, R. S., Justice, A. C., et al. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03327-4 · Cited by 20 · see citing works
Purcell‐Khodr, G., Lee, K. S., Conigrave, J. H., Webster, E., & Conigrave, K. M. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00204-8 · Cited by 21 · see citing works
Mifepristone decreases chronic voluntary ethanol consumption in Rhesus macaques
Jimenez, V. A., Walter, N. A. R., Shnitko, T. A., Newman, N., Diem, K., Vanderhooft, L., Hunt, H., & Grant, K. A. (2020) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000169 · Cited by 20 · see citing works
Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder
Singh‐Tan, S., Torres‐Lockhart, K., Jakubowski, A. U., Lu, T. Y., Starrels, J. L., Lima, P. D., Arnsten, J. H., Nahvi, S., & Southern, W. N. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08202-7 · Cited by 21 · see citing works
Imaginal retraining reduces alcohol craving in problem drinkers: A randomized controlled trial
Moritz, S., Paulus, A. M., Hottenrott, B., Weierstall, R., Gallinat, J., & Kühn, S. (2019) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2019.04.001 · Cited by 20 · see citing works
Dimitropoulos, E., Bertucci, S., & Wong, K. R. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1449172 · Cited by 20 · see citing works
Kirchoff, R. W., Mohammed, N. M., McHugh, J., Markota, M., Kingsley, T. C., Leung, J. G., Burton, M., & Chaudhary, R. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.01.013 · Cited by 19 · see citing works
Rehm, J. T., Assanangkornchai, S., Hendershot, C. S., Franklin, A., Neufeld, M., Hassan, A. S., & Shield, K. D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01496-5 · Cited by 23 · see citing works
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · BMC Public Health · doi:10.1186/s12889-023-15152-6 · Cited by 18 · see citing works
Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care
Bernstein, E. Y., Guo, N., Goto, T., & Rothberg, M. B. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06454-1 · Cited by 18 · see citing works
Qeadan, F., Mensah, N. A., Gu, L. Y., Madden, E. F., Venner, K. L., & English, K. C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168884 · Cited by 17 · see citing works
Chockalingam, L., Burnham, E. L., & Jolley, S. E. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14837 · Cited by 17 · see citing works
The impact of COVID‐19 on trends in alcohol use disorder treatment in Veterans Health Administration
Perumalswami, P., Kilpatrick, S., Frost, M. C., Adams, M. A., Kim, H. M., Zhang, L., & Lin, L. A. (2023) · Addiction · doi:10.1111/add.16156 · Cited by 17 · see citing works
Haque, L., & Leggio, L. (2024) · Hepatology · doi:10.1097/hep.0000000000000996 · Cited by 19 · see citing works
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder
Ellis, M. S., Xu, K. Y., Tardelli, V. S., Fidalgo, T. M., Buttram, M. E., & Grucza, R. A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.3145 · Cited by 16 · see citing works
Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population
Huskamp, H. A., Reif, S., Greenfield, S. F., Normand, S. T., & Busch, A. B. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06073-w · Cited by 16 · see citing works
Busch, A. B., Mehrotra, A., Greenfield, S. F., Uscher‐Pines, L., Rose, S., & Huskamp, H. A. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108920 · Cited by 16 · see citing works
Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders
Jiang, X., Parker, R. L., Vouri, S. M., Lo‐Ciganic, W., Diaby, V., Henry, L. L., & Park, H. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.04.013 · Cited by 15 · see citing works
Integrative Pharmacology in the Treatment of Substance Use Disorders
Donlon, J., Kumari, P., Varghese, S. P., Bai, M. Y., Florentin, O. D., Frost, E. D., Banks, J., Vadlapatla, N., Kam, O., Shad, M. U., et al. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2293854 · Cited by 15 · see citing works
Frost, M. C., Matson, T. E., Richards, J. A., Lee, A. K., Achtmeyer, C. E., Bradley, K. A., & Williams, E. C. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2074602 · Cited by 15 · see citing works
Mignogna, K. M., Bacanu, S., Riley, B. P., Wolen, A. R., & Miles, M. F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0202063 · Cited by 15 · see citing works
Neurobiology and the Treatment of Alcohol Use Disorder: A Review of the Evidence Base
Donato, S., & Ray, L. A. (2023) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s409943 · Cited by 17 · see citing works
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
Higuchi, S., Takahashi, M., Murai, Y., Tsuneyoshi, K., Nakamura, I., Meulien, D., & Miyata, H. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13017 · Cited by 14 · see citing works
- Authors
- Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Mahoney, J., Pasic, J., Weaver, M., Wills, C. D., McIntyre, J., Kidd, J., Yager, J., & Hong, S.-H.
- Affiliations
- From the APA Practice Guideline Writing Group (Victor I. Reus, M.D., Chair)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2018-01-01
- Volume
- 175
- Issue
- 1
- Pages
- 86-90
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2782206210
- Cited by
- 372
- References
- 20
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 57 · 2023: 70 · 2022: 41 · 2021: 37 · 2020: 28 · 2019: 27 · 2018: 17 · 2017: 1
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- alcoholism, pharmacotherapy, treatment guidelines
- MeSH terms
- Alcoholism, Humans, Patient Care Management, Psychological Techniques, Psychotropic Drugs, United States, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
